QMS Medicosmetics GmbH has been sold to BlueGem Capital Partners
The private shareholders of QMS Medicosmetics GmbH (QMS) have sold the company to BlueGem Capital Partners LLP for an undisclosed consideration.
QMS is a leading premium skin care brand, founded in 1986 by the renowned German former facial surgeon Dr. Erich Schulte. Over the years, Dr. Schulte has formulated a range of 35 scientifically advanced, high performance products, which are appreciated around the world for their efficacy. QMS is almost exclusively available in the spa channel, with in-house developed treatments as well as retail products. There are over 700 QMS locations worldwide, including in some of the world’s best hotels, as well as Liberty in London and KaDeWe in Berlin.
BlueGem Capital Partners LLP is a London based mid-market private equity manager established in 2007, which invests equity in medium- sized business in selected countries in Western Europe.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.
Dr Erich Schulte
Founder, QMS Medicosmetics GmbH
Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more